skip to main content


Title: The Effectiveness of mHealth Interventions Targeting Parents and Youth in Human Papillomavirus Vaccination: Systematic Review
Background

The prevalence of human papillomavirus (HPV) and its related cancers is a major global concern. In the United States, routine HPV vaccination is recommended for youth aged 11 or 12 years. Despite HPV being the most common sexually transmitted infection and the vaccine’s proven efficacy, the vaccination rate among US youth remains below the recommended 80% completion rate. Mobile health (mHealth) interventions have demonstrated promise in improving health. Examining and synthesizing the current evidence about the impact of mHealth interventions on vaccination coverage in youth and intervention characteristics could guide future mHealth interventions aimed at mitigating the vaccination gap and disease burden.

Objective

This study aims to conduct a systematic review to assess the effectiveness of mHealth interventions on parental intent to vaccinate youth against HPV and youth’s vaccine uptake.

Methods

We searched empirical papers through databases including Google Scholar, PubMed, CINAHL, PsycINFO, and Cochrane Library. The inclusion criteria were the following: (1) published between January 2011 and December 2022; (2) using mHealth aimed to improve HPV vaccination rate; (3) targeted unvaccinated youth or their parents; and (4) measured HPV-related knowledge, vaccination intention, or vaccine uptake. Overall, 3 researchers screened and appraised the quality of the eligible papers using the Melnyk Levels of Evidence and the Cochrane Grading of Recommendations Assessment, Development, and Evaluation methodology. Disagreements in search results and result interpretation were resolved through consensus.

Results

Overall, 17 studies that met the inclusion criteria were included in the final review. Most studies were conducted in the United States (14/17, 82%), used a randomized controlled trial design (12/17, 71%), and adopted behavior change theories or a culture-centric approach (10/17, 59%). mHealth interventions included SMS text message reminders, motivational SMS text messages, computer-tailored or tablet-tailored interventions, smartphone apps, web-based tailored interventions, social media (Facebook) campaigns, digital videos, and digital storytelling interventions. Approximately 88% (15/17) of the mHealth interventions demonstrated positive effects on knowledge, intention, or behaviors related to HPV vaccination. Overall, 12% (2/17) reported limited or no intervention impact on vaccine uptake or vaccine series completion. Effective vaccine uptake was commonly seen in interventions based on behavior change theories and those that provided culturally relevant information.

Conclusions

This systematic review identified the impact of mHealth interventions among unvaccinated youth and their parents, which showed improvement in HPV-related knowledge, vaccination intention, or vaccine initiation. The interventions that incorporated theories and culture-centric approaches revealed the most promising results. Although these outcomes are encouraging, future studies are needed to investigate factors associated with the success of interventions using SMS text messaging or social media. More studies are also needed for a better understanding of the intervention elements that boost the responses of age-specific and ethnicity-specific populations.

 
more » « less
Award ID(s):
1828010
PAR ID:
10514436
Author(s) / Creator(s):
; ;
Publisher / Repository:
JMIR Publications Inc.
Date Published:
Journal Name:
JMIR Pediatrics and Parenting
Volume:
6
ISSN:
2561-6722
Page Range / eLocation ID:
e47334
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Introduction

    While vaccines are crucial for disease prevention, disparities in vaccination coverage persist among youths aged 10 to 29 years, including within the United States. Serious games are emerging as a new strategy to address vaccine hesitancy. This systematic review aimed to aggregate and assess the current evidence on game-based interventions to improve youth vaccination rates, evaluating their impact and identifying factors influencing their effectiveness.

    Methods

    This systematic review was conducted through a meticulous search and evaluation of literature from databases including PubMed, Cumulative Index to Nursing and Allied Health Literature database, ProQuest platform, Cochrane Library, and Google Scholar. Studies were included if they (a) were designed with the purpose of improving youth vaccination rates; (b) were published in English; (c) were published between January 2011 and June 2023; and (d) evaluated the effect of game-based interventions. Search terms included Medical Subject Headings terms and keywords of the eligible articles.

    Results

    Out of 269 studies, 11 were included in the final analysis of this review. The earliest study dated back to 2013, with 5 being randomized controlled trial and 6 studies incorporating theoretical models in their design or outcome measures. The findings indicated a generally positive effect of game-based interventions on vaccine-related knowledge. However, the impact on actual vaccine uptake was limited. In-game avatar customization and collaboration games were found as effective tools for player engagement.

    Conclusion

    The review findings indicated that serious games boost vaccine knowledge but lack strong evidence for influencing youth vaccine uptake. More rigorous research and tailored game designs are needed to determine the effectiveness of game-based interventions and effectively address the diverse needs of youth in vaccine decision-making.

     
    more » « less
  2. Background Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. HPV can cause genital warts and multiple types of cancers in females. HPV vaccination is recommended to youth age 11 or 12 years before sexual initiation to prevent onset of HPV-related diseases. For females who have not been vaccinated previously, catch-up vaccines are recommended through age 26. The extent to which catch-up vaccines are beneficial in terms of disease prevention and cost-effectiveness is questionable given that some women may have been exposed to HPV before receiving the catch-up vaccination. This study aims to examine whether the cutoff age of catch-up vaccination should be determined based on an individual woman’s risk characteristic instead of a one-size-fits-all age 26. Methods We developed a microsimulation model to evaluate multiple clinical outcomes of HPV vaccination for different women based on a number of personal attributes. We modeled the impact of HPV vaccination at different ages on every woman and tracked her course of life to estimate the clinical outcomes that resulted from receiving vaccines. As the simulation model is risk stratified, we used extreme gradient boosting to build an HPV risk model estimating every woman’s dynamic HPV risk over time for the lifetime simulation model. Results Our study shows that catch-up vaccines still benefit all women after age 26 from the perspective of clinical outcomes. Women facing high risk of HPV infection are expected to gain more health benefits compared with women with low HPV risk. Conclusions From a cancer prevention perspective, this study suggests that the catch-up vaccine after age 26 should be deliberately considered. 
    more » « less
  3. Abstract

    Even amid the unprecedented public health challenges attributable to the COVID-19 pandemic, opposition to vaccinating against the novel coronavirus has been both prevalent and politically contentious in American public life. In this paper, we theorize that attitudes toward COVID-19 vaccination might “spill over” to shape attitudes toward “postpandemic” vaccination programs and policy mandates for years to come. We find this to be the case using evidence from a large, original panel study, as well as two observational surveys, conducted on American adults during the pandemic. Specifically, we observe evidence of COVID-19 vaccine spillover onto general vaccine skepticism, flu shot intention, and attitudes toward hypothetical vaccines (i.e., vaccines in development), which do not have preexisting attitudinal connotations. Further, these spillover effects vary by partisanship and COVID-19 vaccination status, with the political left and those who received two or more COVID-19 vaccine doses becoming more provaccine, while the political right and the unvaccinated became more anti-vaccine. Taken together, these results point to the salience and politicization of the COVID-19 vaccine impacting non-COVID vaccine attitudes. We end by discussing the implications of this study for effective health messaging.

     
    more » « less
  4. Abstract

    As behavioural science is increasingly adopted by organizations, there is a growing need to assess the robustness and transferability of empirical findings. Here, we investigate the transferability of insights from various sources of behavioural science knowledge to field settings. Across three pre-registered randomized controlled trials (RCTs,N = 314,824) involving a critical policy domain—COVID-19 booster uptake—we field tested text-based interventions that either increased vaccinations in prior field work (RCT1, NCT05586204), elevated vaccination intentions in an online study (RCT2, NCT05586178) or were favoured by scientists and non-experts (RCT3, NCT05586165). Despite repeated exposure to COVID-19 vaccination messaging in our population, reminders and psychological ownership language increased booster uptake, replicating prior findings. However, strategies deemed effective by prediction or intention surveys, such as encouraging the bundling of COVID-19 boosters and flu shots or addressing misconceptions, yielded no detectable benefits over simple reminders. These findings underscore the importance of testing interventions’ transferability to real-world settings.

     
    more » « less
  5. Abstract

    Most studies of policy entrepreneurship seek to understand how entrepreneurs influence the behavior of policy‐makers in the agenda‐setting or decision‐making phases of the policy process. Recent scholarship has sought to understand what role entrepreneurs might play in policy implementation by focusing on their ability to influence bureaucrats' discretion and behavior. However, these studies overlook the potentially critical influence of policy entrepreneurs during the implementation of “opt‐in” policies that require voluntary compliance by individuals to be successful. Here, we consider whether and how a visible policy entrepreneur can impact opt‐in policy implementation, focusing on their credibility—or ability to gain public trust—as a potential driving factor of their influence. Using the empirical context of COVID‐19 vaccination recommendations, we identify Dr. Anthony Fauci as a highly visible policy entrepreneur and assess his influence on individual vaccine intention and uptake. Drawing on data from a novel panel survey of the American public on attitudes about the virus, risk, politics, and vaccination during the first several months of the COVID‐19 vaccine rollout in the United States, we test the relationship between respondent trust in Dr. Fauci and changes in reported intention to vaccinate and vaccination uptake across time. We find that trust in Dr. Fauci is an important predictor for influencing individuals' intention to vaccinate and actual vaccination behavior.

     
    more » « less